Skip to content

Author

E. Messina

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Multicentre evaluation of artificial intelligence risk classification for detection of clinically significant prostate cancer on biparametric MRI.

OBJECTIVES To compare a commercially available artificial intelligence (AI) risk-classification system with PI-RADS for detecting clinically significant prostate cancer (csPCa) on prostate MRI. MATERIALS AND METHODS This retrospective multicentre, multivendor diagnostic accuracy study included men who underwent prost...

Karsten Guenzel, Maarten G. Poirot, Almar van Loon et al. · 0 citations
Review Open access Jan 2026

Prostate imaging scoring systems: indications, interpretation, and clinical impact

Abstract Prostate imaging, and especially multiparametric magnetic resonance imaging (mpMRI), has become central to the diagnosis, risk stratification, treatment planning, and follow-up of prostate cancer. Its widespread adoption has driven the development of structured imaging scoring systems designed to standardize a...

E. Messina, Antonella Borrelli, Georgios Agrotis et al. · 0 citations
Review Open access Oct 2026

Prostate cancer screening with MRI: insights from the ESUR Prostate MRI Working Group.

Prostate-specific antigen (PSA)-based screening for prostate cancer (PCa) remains controversial due to uncertain long-term benefits, overdiagnosis, and overtreatment of indolent disease. Magnetic resonance imaging (MRI) has transformed the diagnostic pathway of PCa and is increasingly explored as a screening tool. This...

Giorgio Brembilla, E. Messina, Tristan Barret et al. · 0 citations
Open access Sep 2026

Head-to-head comparison of MRI-based PI-RR scoring system and 68 Ga-PSMA-PET/CT: enhancing prostate cancer recurrence detection after radical prostatectomy

To compare the diagnostic performance of MRI using the PI-RR scoring system and PSMA-PET/CT in detecting prostate cancer (PCa) local recurrence after radical prostatectomy (RP), and to identify clinical and imaging variables independently associated with recurrence. This retrospective, multicenter study evaluated 119 p...

L. Laschena, Martina Pecoraro, E. Messina et al. · 0 citations
#explainable ai Open access Sep 2026

Current status and future directions of AI in prostate cancer detection on MRI: a special report from the ESUR prostate MRI working group authors.

The gap between AI's research promise and clinical readiness is highlighted, which underscores the need for localvalidation, post-market surveillance, and adequate user training as AI tools become incorporated into diagnostic prostate MRI workflows.

Renato Cuocolo, A. Ponsiglione, G. Agrotis et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.